Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
CGD NOTES
May 14, 2024
This note presents two scenarios for the world economy and development prospects to 2050 based on the forecasting exercises and analysis presented in a series of papers by Philip Adom, Augustin Kwasi Fosu, Dede Woade Gafa, Zack Gehan, Brian Webster, Ranil Dissanayake and Charles Kenny.
WORKING PAPERS
April 23, 2024
This paper explores the potential implications of a declining absolute labor force on economic outcomes. It explores key macroeconomic variables during periods of negative and positive prime age (15-65) population growth (PAPG). These variables include 10-year bond yields, consumer price indices, fe...
POLICY PAPERS
September 05, 2023
The G20 is well placed to provide the leadership needed to ensure that research is a global public good by elevating the discourse on research publishing reform and acknowledging that this is not merely a niche concern for researchers but an important global challenge that underpins human progress.
POLICY PAPERS
May 19, 2023
Most non-DAC cooperation providers show openness to multi-partner engagement for development, but whether and how such openness can be transformed into more active cooperation—if not deeper collaboration—for development, including between DAC and non-DAC actors, remains to be seen.
CGD NOTES
February 22, 2023
This note looks at the development finance provided to multilateral institutions by a group of 13 major economies that have become significant international actors over the past decade. This group—which includes the five BRICS countries—are outside of the mainly Western, high-income countries that a...
POLICY PAPERS
November 28, 2022
The experience of the COVID-19 pandemic—in the US and around the world—highlights the potential feasibility and importance of biomedical R&D for global health and welfare. Drawing from this experience and momentum, this paper argues that the US should deepen its engagement and ambition in global hea...
POLICY PAPERS
November 15, 2022
Antimicrobial drugs form the backbone of modern medicine. Yet over time, use of these drugs selects for mutations that survive exposure to those same drugs, driving “antimicrobial resistance,” or AMR. In the absence of sufficient R&D investment for new antimicrobials, deaths from drug-resistant infe...
POLICY PAPERS
October 04, 2022
In this paper, we report the results of a horizon-scanning exercise to source opportunities for global health R&D investment—that is, high-value potential biomedical innovations which are currently underfunded but which could be transformative for health, quality of life, and health security in LMIC...